Negev Capital
Negev Capital primarily target psychedelic companies with interventions that are at early-mid stages of clinical development.
Founded — · venture_capital
Investment Stages
early_stage_venture
post_ipo
seed
venture
Markets
Investment
Biotech / Pharma